How can we help you?
Semaglutide
- Lowers A1C Levels
- Helps you feel full faster, longer
- Improves the way your body responds to sugars
- Semaglutide is not FDA-approved for weight loss, but may be prescribed if a provider deems it appropriate*
- 24/7 Provider & Nursing support
- Medications, syringes, alcohol swabs
- Weight monitoring via app
- Shipping delivered to your door
- Optional nutritional counseling
Semaglutide is typically administered as a once-weekly subcutaneous injection, meaning it is injected just under the skin, usually in the abdomen, thigh, or upper arm. It's important to rotate the injection site each week to avoid irritation. Always follow the dosing instructions provided by your healthcare provider, starting with a lower dose and gradually increasing based on your body's response. Be sure to use a clean needle for each injection and dispose of it safely. If you miss a dose, take it as soon as you remember, unless it's less than 48 hours before your next scheduled dose. Never double up on doses. For optimal results, use semaglutide in combination with a healthy diet and regular exercise
Common side effects of semaglutide may include nausea, vomiting, diarrhea, constipation, and abdominal pain, especially when starting treatment. Other possible side effects include fatigue, dizziness, and decreased appetite. In rare cases, semaglutide can cause more serious side effects like pancreatitis, gallbladder issues, or allergic reactions. If you experience severe abdominal pain, difficulty breathing, or swelling of the face or throat, seek medical attention immediately. Always consult your healthcare provider about any side effects or concerns you may have.
* This page has been medically reviewed
* Actual price to customer will depend on product and subscription plan purchase.
Important safety information
Important Safety Information for Ozempic (semaglutide) injection
Caution: Risk of Thyroid C-Cell Tumors
In animal studies involving mice and rats, semaglutide (the active component in Ozempic and Wegovy) was associated with thyroid tumors, including thyroid cancer. It is uncertain whether Ozempic may lead to thyroid tumors or a specific thyroid cancer called medullary thyroid carcinoma (MTC) in humans. If you notice any neck lumps, swelling, hoarseness, difficulty swallowing, or shortness of breath, please inform your healthcare provider. These could be signs of thyroid cancer.
Do not use Ozempic if you or any family member has a history of medullary thyroid carcinoma (MTC) or a condition known as Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
What is the FDA-approved use of Ozempic?
Ozempic is a glucagon-like peptide-1 (GLP-1) receptor agonist used for:
- Enhancing glycemic control in patients with type 2 diabetes mellitus, alongside diet and exercise.
- Reducing the risk of major cardiovascular events in patients with type 2 diabetes mellitus and established cardiovascular disease.
Limitations of Use:
- Ozempic has not been studied in patients with a history of pancreatitis.
- Ozempic is not intended for treating type 1 diabetes mellitus.
- Your JRNYS-affiliated provider may suggest Ozempic for chronic weight management (obesity or overweight).
Who should avoid Ozempic?
Do not use Ozempic if:
- You or any family member has a history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
- You have known allergies to semaglutide (the active ingredient in Wegovy or Ozempic).
How should Ozempic be administered?
Ozempic can be taken with or without food. The pre-filled injector pen is self-administered as a subcutaneous injection in the stomach, thigh, or upper arm once a week on the same day each week.
Your JRNYS-affiliated provider will guide you on the treatment plan, which may include dose increases every four weeks.
Do not alter your dosing regimen or discontinue Ozempic without consulting your provider first.
What should I inform my JRNYS-affiliated provider before using Ozempic?
Ozempic can interact with certain medications. It's crucial to disclose all current medications, including prescription, over-the-counter drugs, vitamins, herbal supplements, and dietary supplements to your JRNYS-affiliated provider.
Some medications to be aware of include:
- Drugs for type 1 or type 2 diabetes, such as insulin or sulfonylureas (e.g., Amaryl or Glucotrol XL).
- Ozempic can delay gastric emptying, potentially affecting the absorption of orally taken medications. Your provider can advise on scheduling your medications.
Additionally, share your complete medical history with your provider, especially if you have a history of:
- Type 1 or type 2 diabetes
- Thyroid cancer
- Pancreatitis
- Kidney disease
- Diabetic retinopathy
- Depression
- Suicidal thoughts or behavior
Notify your provider if you are pregnant, planning to become pregnant, or breastfeeding.
If pregnant: Ozempic should not be used during pregnancy. Animal studies suggest potential risks to the unborn baby from Ozempic exposure during pregnancy. Weight loss during pregnancy is not beneficial and may harm the baby.
If of reproductive potential: Discontinue Ozempic at least two months before planned pregnancy, as the drug may persist in the bloodstream.
If breastfeeding: Ozempic was detected in the milk of lactating rats. Inform your JRNYS-affiliated provider if you are breastfeeding before starting Ozempic.
Pregnancy registry: A pregnancy exposure registry monitors outcomes in women exposed to semaglutide (the active ingredient in Ozempic and Ozempic) during pregnancy.
Pregnant women exposed to semaglutide and healthcare providers can contact Novo Nordisk at 1-800-727-6500.
Withholding or providing inaccurate health information to obtain treatment may lead to harm, including death.
What are the most serious side effects to monitor for while taking Ozempic?
If you experience a medical emergency, call 911 or seek immediate medical attention.
Serious side effects associated with Ozempic include:
- Thyroid C-Cell Tumors: While Ozempic's impact on human thyroid C-cell tumors remains uncertain, animal studies revealed an increase in thyroid C-cell tumors, including MTC. Ozempic is contraindicated for patients with a family history of MTC or MEN 2. Notify your provider if you notice neck lumps, swelling, hoarseness, difficulty swallowing, or shortness of breath, as these may indicate thyroid cancer.
- Acute Pancreatitis: Be vigilant for signs of acute pancreatitis, such as persistent severe abdominal pain, possibly radiating to the back, with or without vomiting.
- Diabetic Retinopathy Complications in Patients with Type 2 Diabetes: If you have type 2 diabetes, promptly inform your provider of any changes in vision.
- Never Share a Pen: Sharing Ozempic pens can lead to infections.
- Low Blood Sugar (Hypoglycemia): Ozempic can lower blood glucose, potentially causing low blood sugar in patients with type 2 diabetes using other glucose control medications. Monitor blood sugar levels and watch for signs of low blood sugar, including dizziness, blurred vision, mood changes, sweating, or rapid heartbeat.
- Acute Kidney Injury: In individuals with kidney issues, dehydration from diarrhea, nausea, and vomiting can worsen kidney problems. Ensure adequate hydration to reduce the risk of dehydration.
- Serious Allergic Reactions: Discontinue Ozempic immediately if you experience symptoms of a severe allergic reaction, such as facial swelling, severe rash, rapid heartbeat, breathing difficulties, or fainting.
- Acute Gallbladder Disease: Ozempic may lead to gallbladder problems, including gallstones. Some issues may require surgery. Inform your provider of upper stomach pain, yellowing of skin or eyes (jaundice), fever, or pale stools.
- Increase in Heart Rate: Notify your provider of a rapid resting heart rate.
- Suicidal Behavior and Ideation: Monitor your mental health for sudden changes in mood, behavior, thoughts, or feelings. If you experience new, worsening, or concerning mental changes, contact your healthcare provider promptly.
What are the most common side effects of Ozempic?
Common side effects of Ozempic include:
- Nausea
- Vomiting
- Diarrhea
- Stomach pain
- Constipation
If you experience adverse effects, please report them:
- Contact Novo Nordisk Inc. at 1-833-934-6891
- Contact FDA MedWatch at 1-800-FDA-1088 or visit www.fda.gov/medwatch
This information is not exhaustive. Refer to the full Prescribing Information for complete safety details.
- Monthly plans including medication as little as $189.
- Semaglutide and Tirzepatide (same active ingredient as Ozempic and Zepbound) available.
- No insurance required.
- Fully online medical consultations.
- Medications delivered to your doorstep.
Better Sex.
Confidence and performance when
it matters most.
Mission Driven
At Olliscripts, our mission is to revolutionize healthcare by providing accessible and personalized telemedicine services that enhance well-being and vitality.
We specialize in offering GLP-1 therapies and sexual wellness solutions, with a forward-thinking approach to expanding into regenerative treatments. Our commitment is to empower individuals to achieve optimal health through innovative, science-backed care, delivered with compassion and convenience.